AtriCure (ATRC) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $54.54 +2.98%
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $45.36 million.
2018 Financial Guidance
Management projects 2018 revenue of approximately $190 million to $196 million. Adjusted EBITDA, a non-GAAP measure, is projected to be positive for 2018.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
